VidAU, a trailblazer in AI-driven video creation, has announced a significant milestone with the acquisition of new funding from a prominent undisclosed investor within the industry. This strategic infusion of capital is poised to catapult VidAU’s pioneering efforts in enhancing its intelligent algorithms and AI video models, further solidifying its position as a leader in…
Rejuvenate Bio, a pioneering biotechnology firm specializing in gene therapies, announced today the reception of a $4 million grant from the California Institute for Regenerative Medicine (CIRM) to propel the development of its innovative gene therapy, RJB-0402, aimed at treating desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM) is…
N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…
Cognigy, a pioneer in AI-driven customer service solutions, proudly announces its consecutive victory in the prestigious AI Breakthrough Awards 2024, clinching the title of “Best Natural Language Understanding Solution” for the second year running. Hosted by AI Breakthrough, a leading market intelligence firm, the annual awards program recognizes outstanding achievements in artificial intelligence across various…
Instructure Holdings, Inc. (NYSE: INST), a leading provider of learning management solutions, announced today the successful completion of its acquisition of Scribbles, a prominent K-12 credentialing and records management company based in Charlotte, North Carolina. This strategic move strengthens Instructure’s foothold in the K-12 space by expanding its credentialing network and bolstering its support for…
Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…
VenoStent, Inc., a leading innovator in medical devices aimed at enhancing outcomes for dialysis patients, has successfully closed its Series A funding round, securing $20 million. This round was highlighted by a significant $4 million investment from Norwest Venture Partners, alongside contributions from Good Growth Capital and IAG Capital Partners. Concurrently, the company has been…
ZeroEyes, a pioneer in AI-based gun detection technology, has announced a major milestone with the successful closure of its oversubscribed Series B funding round, raising over $53 million. Leading the investment was Sorenson Capital, joined by Intel Capital, BroadLight Capital, and existing investors, signaling robust support for ZeroEyes’ mission to advance public safety through innovative…
Waypoint Bio, a pioneering biotechnology firm, has secured $14.5 million in seed funding led by Hummingbird Ventures, alongside Recode Ventures and Fifty Years, to advance its cutting-edge approach in developing cell therapies for solid tumors. Founded by MIT alumni Xinchen Wang and David Phizicky, Waypoint Bio harnesses in vivo spatial pooled screening technology to drive…
In a significant move bolstering its commitment to advancing science-driven solutions, Freeflow Ventures has announced the successful raise of $90 million in funding. This includes $50 million from its Fund Two and Opportunity Fund, complementing its existing $25 million Fund One and Special Purpose Vehicles (SPVs). Amidst a challenging venture capital landscape, Freeflow’s doubled fundraising…
